Tag: genomics
-
Viruses Altered to Boost Gene Therapy Delivery
Researchers in Sweden developed a process to improve the targeting of benign viruses for delivering gene therapies to the brain.
-
Synthetic Bio Company Acquired in $2.35B Deal
A company developing protein-like therapies for cancer from synthetic bacteria is being acquired by drug maker Sanofi in a deal valued at $2.35 billion.
-
Broad Inst, Biotech Partner on Immune-Safe Crispr
A company designing synthetic proteins and the Broad Institute are developing ways to reduce the threat of edited genes producing an immune-system response.
-
Engineered Virus Aids Gene Therapy Delivery
A university bio-engineering lab and start-up company are developing synthetic variations of viruses to more reliably deliver gene therapies.
-
Biotech Licenses Gene-Limiting Technology for Allergies
A biotechnology company developing treatments for skin conditions is acquiring a technology for limiting effects of genes causing asthma and allergic reactions.
-
Company, Univ. Lab Partner on Skin Disease Treatment
A company making regenerative skin therapies and a medical school research center are developing a spray-on treatment for a genetic skin disorder.
-
Cell, Gene Therapy R&D/Mfring Center in Works
A consortium of companies, universities, and hospitals are creating an innovation and manufacturing center in the Boston area for cell and gene therapies.
-
Foundations Direct $5M for Neurodegenerative Tests
Two foundations are spending $5 million to develop new diagnostics for frontotemporal degeneration, an inherited neurodegenerative disorder and form of dementia.
-
First Blood Disorder Crispr Treatments Reported
Early results from a clinical trial testing gene editing treatments for inherited blood disorders show the treatments helped patients improve their conditions.
-
T-Cells Engineered to Release Anti-Cancer Proteins
A biotechnology company is developing modified immune system cells programmed to sense and respond to cancer cells with targeted therapeutic proteins.